Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.9.5133

Influence of Perineural Invasion on Survival and Recurrence in Patients with Resected Pancreatic Cancer  

Zhang, Jun-Feng (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Hua, Rong (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Sun, Yong-Wei (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Liu, Wei (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Huo, Yan-Miao (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Liu, De-Jun (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Li, Jiao (Department of General Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.9, 2013 , pp. 5133-5139 More about this Journal
Abstract
Background: Perineural invasion (PNI) has been reported as one of the sources of locoregional recurrence in resected pancreatic cancer (PC). However the impact of PNI in resected pancreatic cancer remains controversial. The purpose of this study was to determine the association between PNI status and clinical outcomes. Methods: Publications were identified which assessed prognostic significance of PNI status in resected pancreatic cancer up to February 2013. A meta-analysis was performed to clarify the association between PNI status and clinical outcomes. Results: A total of 21 studies met the inclusion criteria, covering 4,459 cases. Analysis of these data showed that intrapancreatic PNI was correlated with reduced overall survival only in resected pancreatic ductal adenocarcinoma (PDAC) patients (HR=1.982, 95%CI: 1.526-2.574, p=0.000). Extrapancreatic PNI was correlated with reduced overall survival in all resected pancreatic cancer patients (HR=1.748, 95%CI: 1.372-2.228, p=0.000). Moreover, intrapancreatic PNI status may be associated with tumor recurrence in all resected pancreatic cancer patients (HR=2.714, 95%CI: 1.885-3.906, p=0.000). Conclusion: PNI was an independent and poor prognostic factor in resected PDAC patients. Moreover, intrapancreatic PNI status may be associated with tumor recurrence.
Keywords
Perineural invasion; prognosis; pancreatic nerve plexus; pancreatic ductal adenocarcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bachellier P, Rosso E, Lucescu I, et al (2011). Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A casematched controlled study. J Surg Oncol, 103, 75-84.   DOI   ScienceOn
2 Balentine CJ, Enriquez J, Fisher W, et al (2010). Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg, 14, 1832-7.   DOI
3 Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS (2012) 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res, 174, 12-9.   DOI   ScienceOn
4 Bapat AA, Hostetter G, Von Hoff DD, Han H (2011). Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer, 11, 695-707.   DOI   ScienceOn
5 Barbier L, Turrini O, Gregoire E, et al (2011). Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival. HPB (Oxford), 13, 64-9.   DOI   ScienceOn
6 Ben QW, Wang JC, Liu J, et al (2010). Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol, 17, 2213-21.   DOI
7 Ceyhan GO, Schafer KH, Kerscher AG, et al (2010). Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreaticadenocarcinoma. Ann Surg, 251, 923-31.   DOI   ScienceOn
8 Chatterjee D, Katz MH, Rashid A, et al (2012). Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol, 36, 409-17.   DOI
9 Cheng P, Jin G, Hu X, et al (2012). Analysis of tumorinduced lymphangiogenesis and lymphatic vessel invasion ofpancreatic carcinoma in the peripheral nerve plexus. Cancer Sci, 103, 1756-63.   DOI   ScienceOn
10 Chu CK, Mazo AE, Goodman M, et al (2010). Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Ann Surg Oncol, 17, 502-13.   DOI
11 Fisher SB, Patel SH, Bagci P, et al (2013). An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma: implications for adjuvant treatment. Cancer, 119, 445-53.   DOI   ScienceOn
12 de Jong MC, Li F, Cameron JL, et al (2011). Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol, 103, 656-62.   DOI   ScienceOn
13 Gebhardt C, Meyer W, Reichel M, Wünsch PH (2000). Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg, 385, 14-20.   DOI
14 Farnell MB, Pearson RK, Sarr MG, et al (2005). A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery, 138, 618-28; discussion 628-30.   DOI   ScienceOn
15 Garcea G, Dennison AR, Pattenden CJ, et al (2008). Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP, 9, 99-132.
16 Higgins JPT, Green S (2010) Cochrane Handbook for Systematic Reviews of Interventions. 5.0.
17 Jamieson NB, Denley SM, Logue J, et al (2011). A prospective comparison of the prognosticvalue of tumor- and patientrelated factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol, 18, 2318-28.   DOI   ScienceOn
18 Jamieson NB, Mohamed M, Oien KA, et al (2012). The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol, 19, 3581-90.   DOI   ScienceOn
19 Kayahara M, Nakagawara H, Kitagawa H, Ohta T (2007). The nature of neural invasion by pancreatic cancer. Pancreas, 35, 218-23   DOI   ScienceOn
20 Kanda M, Fujii T, Sahin TT, et al (2010). Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas. Ann Surg, 251, 483-7.   DOI   ScienceOn
21 Kanehara (1996) Japan Pancreas Society. The Classification of Pancreatic Carcinoma, the 1st English edition. Tokyo.
22 Kanehara (2003). Japan Pancreas Society: Classification of Pancreatic Carcinoma, 2nd edt. Tokyo.
23 Kato K, Yamada S, Sugimoto H, et al (2009).Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas, 38, 605-12.   DOI   ScienceOn
24 Kayahara M, Nagakawa T, Konishi I, et al (1991). Clinicopathologic study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol, 10, 105-11
25 Kazanjian KK, Hines OJ, Duffy JP, et al (2008). Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. Arch Surg, 143, 1166-71.   DOI   ScienceOn
26 Kim J, Reber HA, Dry SM, et al (2006). Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut, 55, 1598-1605.   DOI   ScienceOn
27 Kim R, Tan A, Lai KK, et al (2011). Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer, 117, 3126-34.   DOI   ScienceOn
28 Koide N, Yamada T, Shibata R, et al (2006). Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin Cancer Res, 12, 2419-26.   DOI   ScienceOn
29 Kneuertz PJ, Patel SH, Chu CK, et al (2011). Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol, 18, 1327-34.   DOI
30 Maithel SK, Coban I, Kneuertz PJ, et al (2011.) Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection. Ann Surg Oncol, 18, 2699-705.   DOI   ScienceOn
31 Lee SH, Kim H, Hwang JH, et al (2012). Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Pathol Int, 62, 167-75.   DOI   ScienceOn
32 Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009). Perineural invasion in cancer:a review of the literature. Cancer, 115, 3379-91.   DOI   ScienceOn
33 Mancuso A, Calabro F, Sternberg CN (2006). Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol, 58, 231-41.   DOI   ScienceOn
34 Mitsunaga S, Hasebe T, Kinoshita T, et al (2007). Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma and its prognostic impact. Am J Surg Pathol, 31, 1636-44.   DOI   ScienceOn
35 Mitsunaga S, Hasebe T, Iwasaki M, et al (2005). Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas. Cancer Sci, 96, 858-65.   DOI   ScienceOn
36 Murakami Y, Uemura K, Sudo T, et al (2008). Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. J Gastrointest Surg, 12, 534-41.   DOI
37 Mollberg N, Rahbari NN, Koch M, et al (2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg, 254, 882-93.   DOI   ScienceOn
38 Murakami Y, Uemura K, Sudo T, et al (2010).Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. World J Surg, 34, 1900-7.   DOI
39 Nagakawa T, Kayahara M, Ohta T, et al (1991). Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol, 10, 113-9.
40 Murata Y, Hamada T, Kishiwada M, et al (2012). Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabinebased chemoradiotherapy. J Hepatobiliary Pancreat Sci, 19, 413-25.   DOI   ScienceOn
41 Nagai K, Doi R, Katagiri F, et al S (2009).Prognostic value of metastin expression in human pancreatic cancer. J Exp Clin Cancer Res, 21, 28:9.
42 Nagakawa T, Kayahara M, Ueno K, et al (1992a). A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer, 69, 930-5.   DOI
43 Nagakawa T, Kayahara M, Ueno K, et al (1992b). Clinicopathologic study on neural invasion to the extrapancreatic nerve plexus in pancreatic cancer. Hepatogastroenterology, 39, 51-5.
44 Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N (2006). Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Hepatogastroenterology, 53, 447-51.
45 Pawlik TM, Gleisner AL, Cameron JL, et al (2007). Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery, 141, 610-8.   DOI   ScienceOn
46 Nimura Y (2002). Extended surgery in bilio-pancreatic cancer. The Japanese experience. Semin Oncol, 29, 17-22.   DOI
47 Regine WF, Abrams RA (2006). Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol, 33, S10-13.   DOI   ScienceOn
48 Ozaki H, Hiraoka T, Mizumoto R, et al (1999). The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today, 29, 16-22.   DOI
49 Pour PM, Bell RH, Batra SK (2003). Neural invasion in the staging of pancreatic cancer. Pancreas, 26, 322-5.   DOI   ScienceOn
50 Ren F, Xu YC, Wang HX, Tang L, Ma Y (2012). Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop? Pancreatology, 12, 162-9.   DOI   ScienceOn
51 Sahin IH, Shama MA, Tanaka M, et al (2012).. Association of diabetes and perineural invasion in pancreatic cancer. Cancer Med, 1, 357-62.   DOI
52 Schiffman SC, Chu CK, Park J, et al (2011). Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy? Am J Surg, 201, 519-24.   DOI   ScienceOn
53 Sergeant G, Ectors N, Fieuws S, Aerts R, Topal B (2009). Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. Ann Surg Oncol, 16, 3070-9.   DOI
54 Sobin LH, Wittekind C (2002). International Union Against Cancer.TNM Classification of MalignantTumours, 6th edn. New York: Wiley.
55 Shimada K, Nara S, Esaki M, et al (2011). Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas, 40, 464-8.   DOI   ScienceOn
56 Squadroni M, Fazio N(2010). Chemotherapy in pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci, 14, 386-94.
57 Singal AK, Ross WA, Guturu P, et al (2011). Self-expanding metal stents for biliary drainage in patients with respectable pancreatic cancer: single-center experience with 79 cases. Dig Dis Sci, 56, 3678-84.   DOI   ScienceOn
58 Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997). Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg, 21, 195-200.   DOI
59 Stocken DD, Büchler MW, Dervenis C, et al (2005). Metaanalysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer, 92, 1372-81.   DOI   ScienceOn
60 Stolinski C (1995). Structure and composition of the outer connective tissue sheaths of peripheral nerve. J Anat, 186, 123-30.
61 Takahashi H, Ohigashi H, Ishikawa O, et al (2012). Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg, 255, 95-102.   DOI   ScienceOn
62 Turrini O, Paye F, Bachellier P, et al (2013). Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. Eur J Surg Oncol, 39, 171-8.   DOI   ScienceOn
63 Winter JM, Cameron JL, Campbell KA, et al (2006). 1423 pancreaticoduodenectomies for pancreatic cancer: A singleinstitution experience. J Gastrointest Surg, 10, 1199-210; discussion 1210-1.   DOI   ScienceOn
64 Watanabe T, Morinaga S, Akaike M, et al (2012). The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery. Eur J Surg Oncol, 38, 1051-7.   DOI   ScienceOn
65 Xie H, Lin J, Thomas DG, Jiang W, Liu X (2012). Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma. Int J Clin Exp Pathol, 5, 347-55.
66 Waters JA, Schnelldorfer T, Aguilar-Saavedra JR, et al (2011). Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage. J Am Coll Surg, 213, 275-83.   DOI   ScienceOn
67 Xie H, Jiang W, Xiao SY, Liu X (2013). High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma. J Histochem Cytochem, 61, 148-55.   DOI
68 Nakao A, Harada A, Nonami T, Kaneko T, Takagi H(1996). Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas, 12, 357-61.   DOI